AACE: Liraglutide Shows Positive Results in Head to Head Study
Patients more likely to reach A1c target at any given time during 26 weeks' treatment with liraglutide compared with both sitagliptin and exenatide....
GLP-1 Agonists: Increasing Effective Insulin Release
By Wael Diab, RPh, PharmD Candidate University of Colorado College of Pharmacy
The pathophysiology of type 2 diabetes mellitus is complex, consisting of far more physiologic defects than simple...
One Year Study Showed a 36% Loss in Excess Body Weight
Obese individuals completed a 1-year study and lost a mean 35.6% of excess body weight taking….
An Educator's Perspective: Janet Carson, R.N., C.D.E., Largo, FL
Often times there can be difficulty getting approval for the patient to use a GLP-1 analog and so the patient may miss a few days of the medication and possibly decide they don't want to continue. I have gotten in the habit of ordering the...
An Endocrinologist's Perspective: Dr. Falal Taris, MD, Diabetes, Metabolism & Endocrinology, Internal Medicine
I have been using GLP-1 analogs with my patients for the past five years and have seen many patients find reasons to stop using the medication. They complain about nausea, they complain about the cost, they say the needle hurts and they have even...
A Primary Care Physician's Perspective: Dr. Norris Brown, Austin, TX
When the GLP-1 analogs first came out I was slow to start using them. As a primary care physician in a busy multi-practitioner office I was used to working with oral medications for diabetes, and only as a last resort would I put patients on...
Editor's Desk: Keeping Your Patients on Track with GLP-1 Therapy
Most clinicians I work with or have chatted with want to get their patients in optimal control of their glucose levels. We all work hard to find that right combination of medication, food choices, and physical activity that will achieve our...
GLP-1 and Appetite Suppression
There has been an increased use of GLP-1 analogs in patients with diabetes over the past two years as the advent of daily dosing has made medication adherence simpler and more clinicians are comfortable with the available choices.
GLP-1 a Good Choice for Glycemic Control?
The top three drugs for the reduction of A1c levels are biphasic insulin, glucagon-like peptide 1 (GLP-1) analogs, and….
GLP-1 Analogs and DeFronzo's Octet
For nearly 2 decades now, GLP-1 has been heavily investigated as the most promising therapy target in type 2 diabetes patients....
Incretins, Part 1 of 7
This first of seven sets of Homerun Slides begins with GLP-1 physiology, then examines ...
GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 1 of 4
Topics covered include the clinical effects of GLP-1 agonists and DPP-4 inhibitors stemming...
